|
|
|
|
| LEADER |
01533nam a2200469 i 4500 |
| 003 |
CtWfDGI |
| 020 |
|
|
|a 9781845936570
|
| 040 |
|
|
|a CtWfDGI
|c CtWfDGI
|
| 082 |
0 |
4 |
|a 615.1
|
| 245 |
0 |
0 |
|a Antimicrobial peptides:
|b discovery, design and novel therapeutic strategies
|
| 260 |
|
|
|a UK
|b CAB International
|c 2010
|
| 300 |
|
|
|a 1 online resource (xvii, 230 pages) :
|
| 500 |
|
|
|a CAB International
|
| 546 |
|
|
|a English
|
| 650 |
|
0 |
|a Peptide antibiotics.
|
| 650 |
1 |
2 |
|a Antimicrobial Cationic Peptides.
|
| 650 |
2 |
2 |
|a Anti-Infective Agents.
|
| 650 |
2 |
2 |
|a Drug Design.
|
| 650 |
2 |
2 |
|a Immunity, Innate.
|
| 650 |
|
4 |
|a Research.
|
| 650 |
|
4 |
|a Pesticides and Drugs; Control, (New March 2000)
|
| 650 |
|
4 |
|a Pesticides and Drugs; Chemistry and Formulation, (New March 2000)
|
| 650 |
|
4 |
|a Prion, Viral, Bacterial and Fungal Pathogens of Humans, (New March 2000)
|
| 650 |
|
7 |
|a Animals.
|
| 650 |
|
7 |
|a Bacteria.
|
| 650 |
|
7 |
|a Plants.
|
| 650 |
|
7 |
|a Antimicrobial properties.
|
| 650 |
|
7 |
|a Bioinformatics.
|
| 650 |
|
7 |
|a Biophysics.
|
| 650 |
|
7 |
|a Classification.
|
| 650 |
|
7 |
|a Databases.
|
| 650 |
|
7 |
|a Drug development.
|
| 650 |
|
7 |
|a Medical research.
|
| 650 |
|
7 |
|a Mode of action.
|
| 650 |
|
7 |
|a Nomenclature.
|
| 650 |
|
7 |
|a Peptides.
|
| 650 |
|
7 |
|a Therapy.
|
| 700 |
1 |
|
|a Wang, Guangshun,
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1079/9781845936570.0000
|
| 942 |
|
|
|2 ddc
|c EB
|
| 999 |
|
|
|c 140993
|d 140993
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_100000000000000
|7 0
|8 EB
|9 157241
|a KAUCLV
|b KAUCLV
|c EB
|d 2017-10-13
|o 615.1
|p EB426
|r 2017-10-13
|w 2017-10-13
|y EB
|